Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
BMC Cancer
|
July 5, 2024
Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
Mélanie Casile, Gilles Albrand, Clément Lahaye, et al.
BMC Cancer
|
May 30, 2024
Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
Mélanie Casile, Gilles Albrand, Clément Lahaye, et al.
Pediatric Blood & Cancer
|
December 14, 2020
Double L611S/V617F JAK2 mutation in a child with erythrocytosis
Benjamin Lebecque, Victoria Grèze, Thomas Tassin, et al.
Cancer
|
October 26, 2025
Optimizing Wilms tumor 1 thresholds for measurable residual disease monitoring in acute myeloid leukemia: Improved sensitivity and concordance with nucleophosmin 1 in a single-center validation study
Sabrina Barriere, Céline Bourgne, Thomas Tassin, et al.
Cancers
|
April 23, 2022
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients
Elsa Maitre, Cécile Tomowiak, Benjamin Lebecque, et al.
British Journal of Haematology
|
March 3, 2024
Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up
Benjamin Lebecque, Joevin Besombes, Louis-Thomas Dannus, et al.
Cancers
|
October 14, 2022
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
Benjamin Lebecque, Celine Bourgne, Chinmay Munje, et al.
Scientific Reports
|
March 18, 2021
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34<sup>-</sup> and immature CD34<sup>+</sup> cells
Marc G Berger, Benjamin Lebecque, Thomas Tassin, et al.
Annals of Hematology
|
April 1, 2025
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2<sup>V617F</sup> variant allelic fraction in a real-world cohort
Benjamin Lebecque, Carolyne Croizier, Thomas Tassin, et al.
Ejhaem
|
July 18, 2022
Mast cell density and its clinical relevance in Waldenström's macroglobulinemia
Richard Lemal, Stéphanie Poulain, Albane Ledoux-Pilon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
BMC Cancer
|
July 5, 2024
Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
Mélanie Casile, Gilles Albrand, Clément Lahaye, et al.
BMC Cancer
|
May 30, 2024
Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
Mélanie Casile, Gilles Albrand, Clément Lahaye, et al.
Pediatric Blood & Cancer
|
December 14, 2020
Double L611S/V617F JAK2 mutation in a child with erythrocytosis
Benjamin Lebecque, Victoria Grèze, Thomas Tassin, et al.
Cancer
|
October 26, 2025
Optimizing Wilms tumor 1 thresholds for measurable residual disease monitoring in acute myeloid leukemia: Improved sensitivity and concordance with nucleophosmin 1 in a single-center validation study
Sabrina Barriere, Céline Bourgne, Thomas Tassin, et al.
Cancers
|
April 23, 2022
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients
Elsa Maitre, Cécile Tomowiak, Benjamin Lebecque, et al.
British Journal of Haematology
|
March 3, 2024
Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up
Benjamin Lebecque, Joevin Besombes, Louis-Thomas Dannus, et al.
Cancers
|
October 14, 2022
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
Benjamin Lebecque, Celine Bourgne, Chinmay Munje, et al.
Scientific Reports
|
March 18, 2021
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34<sup>-</sup> and immature CD34<sup>+</sup> cells
Marc G Berger, Benjamin Lebecque, Thomas Tassin, et al.
Annals of Hematology
|
April 1, 2025
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2<sup>V617F</sup> variant allelic fraction in a real-world cohort
Benjamin Lebecque, Carolyne Croizier, Thomas Tassin, et al.
Ejhaem
|
July 18, 2022
Mast cell density and its clinical relevance in Waldenström's macroglobulinemia
Richard Lemal, Stéphanie Poulain, Albane Ledoux-Pilon, et al.
Page
of 3